Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanqing Zhitong Ointment is a Traditional Chinese Medicine (TCM) topical preparation designed for acupoint application (tiē fū). Developed by the Beijing Yanqing District Hospital of Traditional Chinese Medicine, it is primarily indicated for the treatment of chronic non-specific low back pain. The ointment is typically applied to specific acupuncture points, such as Shenshu (BL23), Dachangshu (BL25), and Ashi points, often in conjunction with manual acupuncture. Its therapeutic mechanism is based on the transdermal absorption of herbal active ingredients that aim to promote blood circulation, resolve stasis, and provide local analgesic and anti-inflammatory effects. Clinical trials have investigated its efficacy as a non-invasive adjunct or alternative to standard acupuncture for improving pain scores (e.g., McGill Pain Questionnaire) and functional mobility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanqing Zhitong Ointment.